InSilico Is on a Mission: Be No. 1 in China, Create ‘God Drug’ With AI
The pharma company, the first to use generative AI to develop a drug that reached clinical trials, is betting longevity treatments will fuel its next phase of growth.
Connecting Global Economies
The pharma company, the first to use generative AI to develop a drug that reached clinical trials, is betting longevity treatments will fuel its next phase of growth.